Adenosine A2A Receptor: A Target for Regulating Renal Interstitial Fibrosis in Obstructive Nephropathy

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Xiao, Hang ^a,b   Shen, Hai Ying ^b,c   Liu, Wei ^b   Xiong, Ren ping ^b   Li, Ping ^b   Meng, Gang ^a   Yang, Nan ^b   Chen, Xing ^b   Si, Liang Yi ^a   Zhou, Yuan Guo ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c LEGACY RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; ALPHA SMOOTH MUSCLE ACTIN; CELL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE 3; PROTEIN ROCK1; RHO KINASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UVOMORULIN; 2 (4 (2 CARBOXYETHYL)PHENETHYLAMINO) 5' N ETHYLCARBOXAMIDOADENOSINE; 2-(4-(2-CARBOXYETHYL)PHENETHYLAMINO)-5'-N-ETHYLCARBOXAMIDOADENOSINE; ADENOSINE; ADENOSINE A2 RECEPTOR AGONIST; BIOLOGICAL MARKER; DRUG DERIVATIVE; PHENETHYLAMINE DERIVATIVE; ROCK1 PROTEIN, MOUSE;

ADENOSINE A2A RECEPTOR GENE; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE EXACERBATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE; GENE ACTIVATION; GENE INACTIVATION; GENETIC MANIPULATION; KIDNEY FIBROSIS; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ROCK1 GENE; TRANSFORMING GROWTH FACTOR BETA1 GENE; URETER OBSTRUCTION; WILD TYPE; ANIMAL; CELL MOTION; DISEASE MODEL; DRUG EFFECT; FIBROSIS; GENE EXPRESSION; GENETICS; HUMAN; KIDNEY; KNOCKOUT MOUSE; METABOLISM; NEPHRITIS; PATHOLOGY;

MUS;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; ANIMALS; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; DISEASE MODELS, ANIMAL; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; GENE EXPRESSION; HUMANS; KIDNEY; MICE; MICE, KNOCKOUT; NEPHRITIS; PHENETHYLAMINES; RECEPTOR, ADENOSINE A2A; RHO-ASSOCIATED KINASES; TRANSFORMING GROWTH FACTOR BETA1; URETERAL OBSTRUCTION;

EID: 84876030008     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060173     Document Type: Article

References (48)

1. Isaka Y, Takahara S, Imai E, (2008) Chronic deteriorating renal function and renal fibrosis. Contrib Nephrol 159: 109-121.
2. Pannarale G, Carbone R, Del Mastro G, Gallo C, Gattullo V, et al. (2010) The aging kidney: structural changes. J Nephrol 23Suppl 15: S37-40.
3. Strutz F, (2001) Potential methods to prevent interstitial fibrosis in renal disease. Expert Opin Investig Drugs 10: 1989-2001.
4. Liu Y, (2011) Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7: 684-696.
5. Mucsi I, Rosivall L, (2007) Epithelial-mesenchymal transition in renal tubular cells in the pathogenesis of progressive tubulo-interstitial fibrosis. Acta Physiol Hung 94: 117-131.
6. Iwano M, (2010) EMT and TGF-beta in renal fibrosis. Front Biosci (Schol Ed) 2: 229-238.
7. Zeisberg M, Neilson EG, (2010) Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 21: 1819-1834.
8. Tan X, Li Y, Liu Y, (2007) Therapeutic role and potential mechanisms of active Vitamin D in renal interstitial fibrosis. J Steroid Biochem Mol Biol 103: 491-496.
9. Hao S, He W, Li Y, Ding H, Hou Y, et al. (2011) Targeted inhibition of beta-catenin/CBP signaling ameliorates renal interstitial fibrosis. J Am Soc Nephrol 22: 1642-1653.
10. Mazzon E, Esposito E, Impellizzeri D, Di Paola R, Melani A, et al. (2011) CGS 21680, an agonist of the adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis. J Rheumatol 38: 2119-2129.
11. Impellizzeri D, Di Paola R, Esposito E, Mazzon E, Paterniti I, et al. (2011) CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation. Eur J Pharmacol 668: 305-316.
12. Ferenbach DA, Hughes J, (2011) Adenosine A(2A) agonists as therapy for glomerulonephritis. Kidney Int 80: 329-331.
13. Garcia GE, Truong LD, Chen JF, Johnson RJ, Feng L, (2011) Adenosine A(2A) receptor activation prevents progressive kidney fibrosis in a model of immune-associated chronic inflammation. Kidney Int 80: 378-388.
14. Zhang L, Yang N, Wang S, Huang B, Li F, et al. (2011) Adenosine 2A receptor is protective against renal injury in MRL/lpr mice. Lupus 20: 667-677.
15. Sohail MA, Hashmi AZ, Hakim W, Watanabe A, Zipprich A, et al. (2009) Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition. Hepatology 49: 185-194.
16. Klahr S, Morrissey J, (2002) Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283: F861-875.
17. Vaughan ED Jr, Marion D, Poppas DP, Felsen D, (2004) Pathophysiology of unilateral ureteral obstruction: studies from Charlottesville to New York. J Urol 172: 2563-2569.
18. Harris RC, Neilson EG, (2006) Toward a unified theory of renal progression. Annu Rev Med 57: 365-380.
19. Tapmeier TT, Fearn A, Brown K, Chowdhury P, Sacks SH, et al. (2010) Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction. Kidney Int 78: 351-362.
20. Tian YC, Fraser D, Attisano L, Phillips AO, (2003) TGF-beta1-mediated alterations of renal proximal tubular epithelial cell phenotype. Am J Physiol Renal Physiol 285: F130-142.
21. Chen JF, Huang Z, Ma J, Zhu J, Moratalla R, et al. (1999) A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci 19: 9192-9200.
22. Moriyama T, Kawada N, Ando A, Yamauchi A, Horio M, et al. (1998) Up-regulation of HSP47 in the mouse kidneys with unilateral ureteral obstruction. Kidney Int 54: 110-119.
23. Mao H, Li Z, Zhou Y, Zhuang S, An X, et al. (2008) HSP72 attenuates renal tubular cell apoptosis and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 295: F202-214.
24. Wu G, Tu Y, Jia R, (2010) The influence of fasudil on the epithelial-mesenchymal transdifferentiation of renal tubular epithelial cells from diabetic rats. Biomed Pharmacother 64: 124-129.
25. Zheng G, Wang Y, Mahajan D, Qin X, Alexander SI, et al. (2005) The role of tubulointerstitial inflammation. Kidney Int Suppl: S96-100.
26. Tipping PG, Holdsworth SR, (2006) T cells in crescentic glomerulonephritis. J Am Soc Nephrol 17: 1253-1263.
27. Strutz F, Neilson EG (1994) The role of lymphocytes in the progression of interstitial disease. Kidney Int Suppl 45: S106-110.
28. Yang N, Isbel NM, Nikolic-Paterson DJ, Li Y, Ye R, et al. (1998) Local macrophage proliferation in human glomerulonephritis. Kidney Int 54: 143-151.
29. Robertson H, Ali S, McDonnell BJ, Burt AD, Kirby JA, (2004) Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition. J Am Soc Nephrol 15: 390-397.
30. Vielhauer V, Anders HJ, Mack M, Cihak J, Strutz F, et al. (2001) Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. J Am Soc Nephrol 12: 1173-1187.
31. Eis V, Luckow B, Vielhauer V, Siveke JT, Linde Y, et al. (2004) Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. J Am Soc Nephrol 15: 337-347.
32. Kitagawa K, Wada T, Furuichi K, Hashimoto H, Ishiwata Y, et al. (2004) Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 165: 237-246.
33. Anders HJ, Vielhauer V, Frink M, Linde Y, Cohen CD, et al. (2002) A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J Clin Invest 109: 251-259.
34. Lukashev D, Ohta A, Apasov S, Chen JF, Sitkovsky M, (2004) Cutting edge: Physiologic attenuation of proinflammatory transcription by the Gs protein-coupled A2A adenosine receptor in vivo. J Immunol 173: 21-24.
35. Sitkovsky M, Lukashev D, Deaglio S, Dwyer K, Robson SC, et al. (2008) Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells. Br J Pharmacol 153Suppl 1: S457-464.
36. Pozdzik AA, Salmon IJ, Husson CP, Decaestecker C, Rogier E, et al. (2008) Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy. Nephrol Dial Transplant 23: 2480-2491.
37. Tang TT, Yuan J, Zhu ZF, Zhang WC, Xiao H, et al. (2012) Regulatory T cells ameliorate cardiac remodeling after myocardial infarction. Basic Res Cardiol 107: 232.
38. Ohta A, Kini R, Subramanian M, Madasu M, Sitkovsky M, (2012) The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway. Front Immunol 3: 190.
39. Zhou B, Buckley ST, Patel V, Liu Y, Luo J, et al. (2012) Troglitazone attenuates TGF-beta1-induced EMT in alveolar epithelial cells via a PPARgamma-independent mechanism. PLoS One 7: e38827.
40. Masszi A, Di Ciano C, Sirokmany G, Arthur WT, Rotstein OD, et al. (2003) Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiol Renal Physiol 284: F911-924.
41. Prakash J, de Borst MH, Lacombe M, Opdam F, Klok PA, et al. (2008) Inhibition of renal rho kinase attenuates ischemia/reperfusion-induced injury. J Am Soc Nephrol 19: 2086-2097.
42. Kalaji R, Wheeler AP, Erasmus JC, Lee SY, Endres RG, et al. (2012) ROCK1 and ROCK2 regulate epithelial polarisation and geometric cell shape. Biol Cell.
43. Baum B, Georgiou M, (2011) Dynamics of adherens junctions in epithelial establishment, maintenance, and remodeling. J Cell Biol 192: 907-917.
44. Otsu K, Kishigami R, Fujiwara N, Ishizeki K, Harada H, (2011) Functional role of Rho-kinase in ameloblast differentiation. J Cell Physiol 226: 2527-2534.
45. Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, et al. (2001) Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 12: 27-36.
46. Lee J, Hwang L, Ha H, (2012) Adenosine receptors are up-regulated in unilateral ureteral obstructed rat kidneys. Transplant Proc 44: 1166-1168.
47. Day YJ, Huang L, McDuffie MJ, Rosin DL, Ye H, et al. (2003) Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J Clin Invest 112: 883-891.
48. Fu P, Liu F, Su S, Wang W, Huang XR, et al. (2006) Signaling mechanism of renal fibrosis in unilateral ureteral obstructive kidney disease in ROCK1 knockout mice. J Am Soc Nephrol 17: 3105-3114.